N1,N3-BIS(2-MERCAPTOETHYL) ISOPHTHALAMIDE

( DrugBank: - / KEGG DRUG: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
5	進行性核上性麻痺	1

告示番号	疾患名（ページ内リンク）	臨床試験数
17	多系統萎縮症	1

5. 進行性核上性麻痺

臨床試験数 : 89 / 薬物数 : 107 - (DrugBank : 40) / 標的遺伝子数 : 65 - 標的パスウェイ数 : 108

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-000506-34-SI (EUCTR)	04/02/2019	09/03/2018	EMERA006- A pilot, exploratory, randomised, placebo-controlled, double blinded, cross-over, Phase 2a ...	EMERA006- A pilot, exploratory, randomised, placebo-controlled, double blinded, cross-over, Phase 2a ...	PSP or MSA;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Product Name: NBMI Product Code: NBMI INN or Proposed INN: emeramide Other descriptive name: N1,N3-BIS( ...	NBMI Science Ltd.	NULL	Not Recruiting			Female: yes Male: yes	20	Phase 2	Slovenia

臨床試験数 : 119 / 薬物数 : 138 - (DrugBank : 44) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 111

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-000506-34-SI (EUCTR)	04/02/2019	09/03/2018	EMERA006- A pilot, exploratory, randomised, placebo-controlled, double blinded, cross-over, Phase 2a ...	EMERA006- A pilot, exploratory, randomised, placebo-controlled, double blinded, cross-over, Phase 2a ...	PSP or MSA;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Product Name: NBMI Product Code: NBMI INN or Proposed INN: emeramide Other descriptive name: N1,N3-BIS( ...	NBMI Science Ltd.	NULL	Not Recruiting			Female: yes Male: yes	20	Phase 2	Slovenia